Interleukin enhancer-binding factor 3 (ILF3) (N-Term) Antikörper
Kurzübersicht für Interleukin enhancer-binding factor 3 (ILF3) (N-Term) Antikörper (ABIN2780867)
Target
Alle Interleukin enhancer-binding factor 3 (ILF3) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- N-Term
-
Verwendungszweck
- ILF3 Antibody - N-terminal region
-
Sequenz
- IFVNDDRHVM AKHSSVYPTQ EELEAVQNMV SHTERALKAV SDWIDEQEKG
-
Spezifität
- The immunizing peptide used to raise this antibody is 100 % homologous to isoform 2 (702aa, 76 kDa), 3 (764aa, 83 kDa), 4 (698aa, 76 kDa) and 5 (690aa, 75 kDa), 6 (706aa, 77 kDa) and 7 (898aa, 96 kDa) of human ILF3.
-
Homologie
- Cow: 100%, Dog: 100%, Guinea Pig: 100%, Horse: 100%, Human: 100%, Mouse: 100%, Rabbit: 100%, Rat: 100%, Zebrafish: 86%
-
Produktmerkmale
- This is a rabbit polyclonal antibody against ILF3. It was validated on Western Blot and immunohistochemistry.
-
Aufreinigung
- Affinity Purified
-
Immunogen
- The immunogen is a synthetic peptide directed towards the N terminal region of human ILF3
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Kommentare
-
We also sell a specific blocking peptide that can be used in combination with this antibody. You can find the blocking peptide under ABIN8103403
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.5 mg/mL
-
Buffer
- Purified antibody supplied in 1x PBS buffer with 0.09 % (w/v) sodium azide and 2 % sucrose.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- prevent freeze-thaw cycles
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- For short term use, store at 2-8C up to 1 week. For long term storage, store at -20 °C in small aliquots to prevent freeze-thaw cycles.
-
-
- Interleukin enhancer-binding factor 3 (ILF3)
-
Andere Bezeichnung
- ILF3
-
Hintergrund
-
Background Information: Nuclear factor of activated T-cells (NFAT) is a transcription factor required for T-cell expression of interleukin 2. NFAT binds to a sequence in the IL2 enhancer known as the antigen receptor response element 2. In addition, NFAT can bind RNA and is an essential component for encapsidation and protein priming of hepatitis B viral polymerase. NFAT is a heterodimer of 45 kDa and 90 kDa proteins, the larger of which is the product of ILF3.Nuclear factor of activated T-cells (NFAT) is a transcription factor required for T-cell expression of interleukin 2. NFAT binds to a sequence in the IL2 enhancer known as the antigen receptor response element 2. In addition, NFAT can bind RNA and is an essential component for encapsidation and protein priming of hepatitis B viral polymerase. NFAT is a heterodimer of 45 kDa and 90 kDa proteins, the larger of which is the product of this gene. The encoded protein, which is primarily localized to ribosomes, probably regulates transcription at the level of mRNA elongation. At least three transcript variants encoding three different isoforms have been found for this gene.
Gene Name: Interleukin enhancer binding factor 3, 90 kDa
Alternative Symbols: CBTF, DRBF, MMP4, MPP4, NF90, NFAR, NF110, NF90a, NF90b, NF90c, NFAR2, TCP80, DRBP76, NF110b, NFAR-1, NFAR-2, NFAR90, TCP110, MPP4110, NF90ctv, NFAR110, MPHOSPH4, NF-AT-90
Protein Name: Interleukin enhancer-binding factor 3
-
Molekulargewicht
- 95kDa
-
Gen-ID
- 3609
-
NCBI Accession
- NP_004507
-
UniProt
- Q12906
-
Pathways
- M Phase
Target
-